|
 |
perflutren Lipid MicrosphereThis page contains recent news articles, when available, and an overview of perflutren Lipid Microsphere but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Evans blue dye was injected intraperitoneally to stain injured cardiomyocytes, and a perflutren lipid microsphere ultrasound contrast agent was infused ... Journal of Ultrasound in Medicine (subscription) Lantheus Medical Imaging Awarded Second Consecutive Sole-Source … - Oct 24, 2008 Activated DEFINITY ® Vial for (Perflutren Lipid Microsphere) Injectable Suspension is indicated for use in patients with suboptimal echocardiograms to ... International Business Times New Study Published in the American Journal of Cardiology Finds … - Dec 15, 2008 Activated DEFINITY ® Vial for (Perflutren Lipid Microsphere) Injectable Suspension is indicated for use in patients with suboptimal echocardiograms to ... Genetic Engineering News - Genetic Engineering News (press release) Lantheus Medical Imaging Updates DEFINITY(R) Label to Modify Benefit/... - May 13, 2008 Since its launch in 2001, activated DEFINITY(R) Vial For (Perflutren Lipid Microsphere) Injectable Suspension has been administered to over two million ... Genetic Engineering News - Genetic Engineering News (press release) Boxed Warning on Definity - Oct 15, 2007 Micro-bubble contrast agents (marketed as Definity [perflutren lipid microsphere] injectable suspension and Optison [perflutren protein-type a microspheres ... Medscape Bristol-Myers Squibb Medical Imaging Awarded Three-Year Contract For ... - Apr 23, 2005 Administration of activated Definity® ( Vial for Perflutren Lipid Microsphere Injectable Suspension ) occasionally may be associated with QTc prolongation. ... i-newswire.com Bristol-Myers Squibb Medical Imaging Awarded Three-Year Contract For ... - Apr 25, 2005 Administration of activated Definity® ( Vial for Perflutren Lipid Microsphere Injectable Suspension ) occasionally may be associated with QTc prolongation. ... i-newswire.com Worldwide Leader in Diagnostic Medicine is Launched as Lantheus … - Mar 18, 2008 Sestamibi for Injection), DEFINITY(R) Vial for (Perflutren Lipid Microsphere) Injectable Suspension and TechneLite(R) (Technetium Tc99m Generator). ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: Bristol-Myers Squibb Medical Imaging Receives … - Oct 13, 2006 European Commission Marketing Authorisation for its Ultrasound Contrast Agent Luminity(TM)(Perflutren Lipid Microsphere). from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Bristol-Myers Squibb Medical Imaging Receives … - Oct 11, 2006 European Commission Marketing Authorisation for Its Ultrasound Contrast Agent LUMINITY(TM) (perflutren lipid microsphere). from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Morning Alert for Bristol-Myers Squibb Co. - Jun 25, 2007 ...a cardiac perfusion imaging agent; DEFINITY, a vial for perflutren lipid microsphere injectable suspension; and an ultrasound contrast agent. ... Free with registration - M2 Presswire - AccessMyLibrary.com Ultrasound agents tied to fatal cardiac events.(NEWS FROM THE FDA) - Nov 15, 2007 The manufacturers of Definity (perflutren lipid microsphere) injectable suspension and Optison (perflutren protein-type A microspheres for Injection), ... Free with registration - Family Practice News - AccessMyLibrary.com Grants/contracts.(Bristol-Myers Squibb Medical Imaging signe contract... - Apr 28, 2005 ...sole-source contract for Definity (Vial for Perflutren Lipid Microsphere Injectable Suspension), an echocardiography contrast agent. ... Free with registration - Diagnostic Update - AccessMyLibrary.com Market Commentary on Bristol-Myers Squibb Co. - Jun 18, 2007 ...a cardiac perfusion imaging agent; DEFINITY, a vial for perflutren lipid microsphere injectable suspension; and an ultrasound contrast agent. ... Free with registration - M2 Presswire - AccessMyLibrary.com Merger and Acquisition Scenario - Nov 25, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Updated Boxed Warning for Micro-Bubble Contrast Agents - Jul 17, 2008 ...the benefits from the diagnostic information that could be obtained through the use of perflutren lipid microsphere (Definity) injectable suspension or ... DG News In- Depth Research on Bristol-Myers Squibb Co. - Jun 13, 2007 ...a cardiac perfusion imaging agent; DEFINITY, a vial for perflutren lipid microsphere injectable suspension; and an ultrasound contrast agent. ... $4.95 - M2 Presswire - ECNext Merger and Acquisition Scenario - Mar 11, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Press Release: Bristol-Myers Squibb Medical Imaging Awarded Three- … - Apr 21, 2005 ...sole source contract for Definity(R) (Vial for Perflutren Lipid Microsphere Injectable Suspension) -- the leading echocardiography contrast agent in the ... Pay-Per-View - PR Newswire - HighBeam Research New Data on Breast Imaging Using Cardiolite(R) to Be Presented at … - Sep 5, 2008 DEFINITY(R) Vial For (Perflutren Lipid Microsphere) Injectable Suspension, and TechneLite(R) (Technetium Tc99m Generator) and has nearly 700 employees ... RedOrbit Merger and Acquisition Scenario - May 13, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Article: Premier inks deals for contrast media with Bristol-Myers... - Jun 1, 2005 It covers the company's Definity vial for perflutren lipid microsphere injectable suspension. Spending and ... Read all of this article with a FREE trial ... Pay-Per-View - Hospital Materials Management - HighBeam Research New Study Finds Survival Benefit Among Hospitalized Patients … - Dec 22, 2008 ...(Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY®. ... Medical News Today - Medical News Today (press release) Premier inks deals for contrast media with Bristol-Myers Squibb and … - Jun 1, 2005 It covers the company's Definity vial for perflutren lipid microsphere injectable suspension. Spending and savings estimates were not disclosed. ... $4.95 - Hospital Materials Management - ECNext Merger and Acquisition Scenario - Nov 4, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 19, 2007 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere New Data On Breast Imaging Using Cardiolite(R) To Be Presented At … - Sep 8, 2008 DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, and TechneLite® (Technetium Tc99m Generator) and has nearly 700 employees ... Medical News Today - Medical News Today (press release) Merger and Acquisition Scenario - Jan 27, 2007 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 15, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Lantheus Medical Imaging Receives Performance Award From Premier … - Jun 12, 2008 DEFINITY(R) Vial For (Perflutren Lipid Microsphere) Injectable Suspension, and TechneLite(R) (Technetium Tc99m Generator) and has nearly 700 employees ... RedOrbit Press Release: In- Depth Research on Bristol-Myers Squibb Co. - M2 … - Jun 13, 2007 ...a cardiac perfusion imaging agent; DEFINITY, a vial for perflutren lipid microsphere injectable suspension; and an ultrasound contrast agent. ... Pay-Per-View - M2 Presswire - HighBeam Research Merger and Acquisition Scenario - Aug 19, 2006 Target. Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec Visi-Flow Irrigator ... $250.00 - Revere Reports - Revere Bracco Diagnostics Inc. and Lantheus Medical Imaging Enter into … - Sep 23, 2008 DEFINITY(R) Vial For (Perflutren Lipid Microsphere) Injectable Suspension, and TechneLite(R) (Technetium Tc 99m Generator) and has nearly 700 employees ... Genetic Engineering News - Genetic Engineering News (press release) Merger and Acquisition Scenario - Aug 19, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec Visi-Flow Irrigator ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jun 16, 2007 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec SUR-FIT/Active Life ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 16, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 7, 2007 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 26, 2008 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec Visi-Flow Irrigator ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 16, 2006 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 12, 2008 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec DuoLock Curved Tail Closures ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 26, 2008 Definity (Perflutren Lipid Microsphere); ChoiceDM A1cNow; ConvaTec Flexi-Seal Fecal Management System; ConvaTec Visi-Flow Irrigator ... $250.00 - Revere Reports - Revere |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |